Minerva Neurosciences, Inc.
NERVNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $181.94M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.24$12.46
- Volume (live)
- -
- Avg. volume (3M)
- 157.11K
Minerva Neurosciences (NERV) Stock Price & Financial Analysis
Minerva Neurosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.25 - $2.65 |
|---|---|
| 52-Week High | $12.46 |
| 52-Week Low | $2.24 |
| Open | $2.37 |
| Volume (last close) | 137.59K |
| Average Volume (3M) | 157.11K |
| 50-Day MA | $3.83 |
|---|---|
| 200-Day MA | $4.98 |
| 1-Year Change | −50.72% |
| Market Cap | 181.94M |
|---|---|
| Shares Outstanding | 79.10M |
| Price to Book (P/B) | -0.90 |
| EV/EBITDA | -0.53 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Minerva Neurosciences at a Glance
As of the Oct 23, 2026 close, Minerva Neurosciences (NERV) has a market capitalization of $181.94M.
As of its latest reported balance sheet, it holds $24.65M in cash and securities against $0.00 of debt, a net cash position of $24.65M.
Minerva Neurosciences does not currently pay a dividend.
The share price is down 50.7% over the past year. At $2.30 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $2.24 to $12.46, below its 200-day moving average of $4.98.
Frequently Asked Questions About Minerva Neurosciences
What is the current stock price for NERV?
As of the Oct 23, 2026 close, NERV stock trades at $2.30. The 52-week range is $2.24–$12.46, with a day range of $2.25–$2.65.
What is the P/E ratio for NERV?
The P/E ratio (Price-to-Earnings) for NERV is shown in the Key Statistics section. This valuation metric helps compare Minerva Neurosciences, Inc. to industry peers.
Does NERV pay dividends?
Minerva Neurosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NERV?
Analyst ratings and recommendations for NERV are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NERV?
As of the Oct 23, 2026 close, Minerva Neurosciences's market capitalization is $181.9M, classifying it as a micro-cap company. Minerva Neurosciences operates in the Healthcare sector within the Biotechnology industry.